Search

Your search keyword '"Weng, Meng-Yu"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Weng, Meng-Yu" Remove constraint Author: "Weng, Meng-Yu"
34 results on '"Weng, Meng-Yu"'

Search Results

2. Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial

3. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial

10. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial

11. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan : national prospective cohort study

13. Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week , Randomized, Controlled Trial

14. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis

16. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

26. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

27. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus

29. Increased risk of Pneumocystis jiroveciicolonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor

34. Pneumocystis jiroveciiPneumonia in Systemic Lupus Erythematosus From Southern Taiwan

Catalog

Books, media, physical & digital resources